Stocks / NASDAQ / Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc.

Our Opinion

Capricor Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

Company’s requirement for a Research associate

“A position is immediately available within our Research group for a Research Associate to support in vivo drug potency studies and assist existing research efforts. Under the direction of and in coordination with the Animal Surgeon, the position involves data collection, analysis, and other animal related tasks.” (Page 1)

Company Description

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA. [Source: MarketWatch]

Company Website: